Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Suppressed miR-128-3p combined with TERT overexpression predicts dismal outcomes for neuroblastoma.

Autor: Druy AE; Laboratory of Molecular Oncology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.; Laboratory of the Cellular Therapy of Oncohematological Disorders, Research Institute of Medical Cell Technologies, Yekaterinburg, Russian Federation., Tsaur GA; Laboratory of the Cellular Therapy of Oncohematological Disorders, Research Institute of Medical Cell Technologies, Yekaterinburg, Russian Federation.; Pediatric Oncology and Hematology Center, Regional Children's Hospital, Yekaterinburg, Russian Federation.; Chair of Laboratory Medicine, Ural State Medical University, Yekaterinburg, Russian Federation., Shorikov EV; PET-Technology Center of Nuclear Medicine, Yekaterinburg, Russian Federation., Tytgat GAM; Princess Máxima Centre for Pediatric Oncology (PMC), Utrecht, The Netherlands., Fechina LG; Laboratory of the Cellular Therapy of Oncohematological Disorders, Research Institute of Medical Cell Technologies, Yekaterinburg, Russian Federation.; Pediatric Oncology and Hematology Center, Regional Children's Hospital, Yekaterinburg, Russian Federation.

Publikováno v: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2022; Vol. 34 (4), pp. 661-671.

The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experience.

Autor: Dyakonova YY; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Bydanov OI; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia.; Республиканский Republican Scientific and Practical Center for Pediatric Oncology, Hematology, and Immunology, Minsk, Republic of Belarus., Popov AM; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Olshanskaya YV; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Boichenko EG; СПбГУЗ «Children City Hospital №1, Saint-Petersburg, Russia., Aleynikova OV; Республиканский Republican Scientific and Practical Center for Pediatric Oncology, Hematology, and Immunology, Minsk, Republic of Belarus., Maschan MA; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Shelikhova LN; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Litvinov DV; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Khachatryan LA; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Ponomareva NI; Russian Children Clinical Hospital, Moscow, Russia., Fechina LG; Regional Children Clinical Hospital №1, Ekaterinburg, Russia., Novichkova GA; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Pashanov ED; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Karachunskiy AI; Dmitry Rogachev National Research Center for Pediatric Hematology, Oncology, and Immunology, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2018 Aug 17; Vol. 90 (7), pp. 38-50.

[Age-related characteristics of the efficacy of different glucocorticosteroids in the therapy of acute lymphoblastic leukemia].

Autor: Karachunsky AI; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Rumyantseva YV; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Lagoiko SN; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Bührer C; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany., Tallen G; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany., Aleinikova OV; Republican Research and Practical Center for Pediatric Oncology and Hematology, Minsk, Belarus., Bydanov OI; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; Republican Research and Practical Center for Pediatric Oncology and Hematology, Minsk, Belarus., Korepanova NV; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Baidun LV; Russian Children's Clinical Hospital, Ministry of Health of Russia, Moscow, Russia., Nasedkina TV; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Stackelberg AV; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany., Novichkova GA; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Maschan AA; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Litvinov DV; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Ponomareva NI; Russian Children's Clinical Hospital, Ministry of Health of Russia, Moscow, Russia., Kondratchik KL; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia; Morozov City Children's Clinical Hospital, Moscow Healthcare Department, Moscow, Russia., Mansurova EG; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia., Fechina LG; Regional Children's Clinical Hospital One, Yekaterinburg, Russia., Streneva OV; Regional Children's Clinical Hospital One, Yekaterinburg, Russia., Yudina NB; Voronezh Regional Children's Clinical Hospital One, Voronezh, Russia., Sharapova GR; Nizhnevartovsk District Children's Clinical Hospital, Nizhnevartovsk, Khanty-Mansi Autonomic District-Yugra, Russia., Shamardina AV; Nizhny Novgorod Regional Children's Clinical Hospital, Nizhny Novgorod, Russia., Gerbek IE; Tomsk Regional Clinical Hospital, Tomsk, Russia., Shapochnik AP; Orenburg Regional Clinical Oncology Dispensary, Orenburg, Russia., Rumyantsev AG; D. Rogachev Federal Research Clinical Center of Pediatric Hematology, Oncology, and Immunology, Moscow, Russia., Henze G; Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Germany.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2015; Vol. 87 (7), pp. 41-50.

[Prognostic value of bone marrow lesions in children with neuroblastoma detected by flow cytometry].

Autor: Popov AM, Shorikov EV, Verzhditskaia TIu, Tsaur GA, Druĭ AE, Solodovnikov AG, Savel'ev LI, Fechina LG

Publikováno v: Voprosy onkologii [Vopr Onkol] 2014; Vol. 60 (4), pp. 469-75.